In unveiling new dietary guidelines, federal health officials have claimed they are correcting past guidance that created a ...
An expiring FDA program designed to incentivize research in pediatric rare disease may see new life. The Pediatric Rare Disease Priority ...
AstraZeneca has signed one of the largest licensing deals yet with a China-based drug company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results